 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, February 1, 2003, 23(3):961
Transient and Progressive Electrophysiological Alterations in the Corticostriatal Pathway in a Mouse Model of Huntington's Disease
Carlos Cepeda1, Raymond S. Hurst1, Christopher R. Calvert1, Elizabeth Hernández-Echeagaray1, Oanh K. Nguyen1, Emily Jocoy1, Lindsey J. Christian1, Marjorie A. Ariano2, and Michael S. Levine1 1 Mental Retardation Research Center, University of California at Los Angeles, Los Angeles, California 90095, and 2 Department of Neuroscience, Chicago Medical School, North Chicago, Illinois 60064
Alterations in the corticostriatal pathway may precede symptomatology and striatal cell death in Huntington's disease (HD) patients. Here we examined spontaneous EPSCs in striatal medium-sized spiny neurons in slices from a mouse model of HD (R6/2). Spontaneous EPSC frequency was similar in young (3-4 weeks) transgenics and controls but decreased significantly in transgenics when overt behavioral symptoms began (5-7 weeks) and was most pronounced in severely impaired transgenics (11-15 weeks). These differences were maintained after bicuculline or tetrodotoxin, indicating they were specific to glutamatergic input and likely presynaptic in origin. Decreases in presynaptic and postsynaptic protein markers, synaptophysin and postsynaptic density-95, occurred in 11-15 week R6/2 mice, supporting the electrophysiological results. Furthermore, isolated, large-amplitude synaptic events (>100 pA) occurred more frequently in transgenic animals, particularly at 5-7 weeks, suggesting additional dysregulation of cortical inputs. Large events were blocked by tetrodotoxin, indicating a possible cortical origin. Addition of bicuculline and 4-aminopyridine facilitated the occurrence of large events. Riluzole, a compound that decreases glutamate release, reduced these events. Together, these observations indicate that both progressive and transient alterations occur along the corticostriatal pathway in experimental HD. These alterations are likely to contribute to the selective vulnerability of striatal medium-sized spiny neurons.
Key words: Huntington's disease; corticostriatal pathway; glutamatergic activity; EPSCs; mouse models; R6/2
Copyright © 2003 Society for Neuroscience 0270-6474/03/233961-09$05.00/0
This article has been cited by other articles:
J. Palazuelos, T. Aguado, M. R. Pazos, B. Julien, C. Carrasco, E. Resel, O. Sagredo, C. Benito, J. Romero, I. Azcoitia, et al.
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
Brain, November 1, 2009; 132(11): 3152 - 3164.
[Abstract] [Full Text] [PDF]
D. M. Cummings, V. M. Andre, B. O. Uzgil, S. M. Gee, Y. E. Fisher, C. Cepeda, and M. S. Levine
Alterations in Cortical Excitation and Inhibition in Genetic Mouse Models of Huntington's Disease
J. Neurosci., August 19, 2009; 29(33): 10371 - 10386.
[Abstract] [Full Text] [PDF]
J. L. Wacker, S.-Y. Huang, A. D. Steele, R. Aron, G. P. Lotz, Q. Nguyen, F. Giorgini, E. D. Roberson, S. Lindquist, E. Masliah, et al.
Loss of Hsp70 Exacerbates Pathogenesis But Not Levels of Fibrillar Aggregates in a Mouse Model of Huntington's Disease
J. Neurosci., July 15, 2009; 29(28): 9104 - 9114.
[Abstract] [Full Text] [PDF]
F. Kasanetz and O. J. Manzoni
Maturation of Excitatory Synaptic Transmission of the Rat Nucleus Accumbens From Juvenile to Adult
J Neurophysiol, May 1, 2009; 101(5): 2516 - 2527.
[Abstract] [Full Text] [PDF]
P. R. Joshi, N.-P. Wu, V. M. Andre, D. M. Cummings, C. Cepeda, J. A. Joyce, J. B. Carroll, B. R. Leavitt, M. R. Hayden, M. S. Levine, et al.
Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease
J. Neurosci., February 25, 2009; 29(8): 2414 - 2427.
[Abstract] [Full Text] [PDF]
R. K. Graham, M. A. Pouladi, P. Joshi, G. Lu, Y. Deng, N.-P. Wu, B. E. Figueroa, M. Metzler, V. M. Andre, E. J. Slow, et al.
Differential Susceptibility to Excitotoxic Stress in YAC128 Mouse Models of Huntington Disease between Initiation and Progression of Disease
J. Neurosci., February 18, 2009; 29(7): 2193 - 2204.
[Abstract] [Full Text] [PDF]
T. B. Brown, A. I. Bogush, and M. E. Ehrlich
Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse
Hum. Mol. Genet., October 15, 2008; 17(20): 3095 - 3104.
[Abstract] [Full Text] [PDF]
H. Runne, E. Regulier, A. Kuhn, D. Zala, O. Gokce, V. Perrin, B. Sick, P. Aebischer, N. Deglon, and R. Luthi-Carter
Dysregulation of Gene Expression in Primary Neuron Models of Huntington's Disease Shows That Polyglutamine-Related Effects on the Striatal Transcriptome May Not Be Dependent on Brain Circuitry
J. Neurosci., September 24, 2008; 28(39): 9723 - 9731.
[Abstract] [Full Text] [PDF]
M. Gray, D. I. Shirasaki, C. Cepeda, V. M. Andre, B. Wilburn, X.-H. Lu, J. Tao, I. Yamazaki, S.-H. Li, Y. E. Sun, et al.
Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice
J. Neurosci., June 11, 2008; 28(24): 6182 - 6195.
[Abstract] [Full Text] [PDF]
A. J. Milnerwood and L. A. Raymond
Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load
J. Physiol., December 15, 2007; 585(3): 817 - 831.
[Abstract] [Full Text] [PDF]
H. B. Fernandes, K. G. Baimbridge, J. Church, M. R. Hayden, and L. A. Raymond
Mitochondrial Sensitivity and Altered Calcium Handling Underlie Enhanced NMDA-Induced Apoptosis in YAC128 Model of Huntington's Disease
J. Neurosci., December 12, 2007; 27(50): 13614 - 13623.
[Abstract] [Full Text] [PDF]
E. C. Stack, A. Dedeoglu, K. M. Smith, K. Cormier, J. K. Kubilus, M. Bogdanov, W. R. Matson, L. Yang, B. G. Jenkins, R. Luthi-Carter, et al.
Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice
J. Neurosci., November 21, 2007; 27(47): 12908 - 12915.
[Abstract] [Full Text] [PDF]
N. Wu, C. Cepeda, X. Zhuang, and M. S. Levine
Altered Corticostriatal Neurotransmission and Modulation in Dopamine Transporter Knock-Down Mice
J Neurophysiol, July 1, 2007; 98(1): 423 - 432.
[Abstract] [Full Text] [PDF]
D. M. Cummings, A. J. Milnerwood, G. M. Dallerac, V. Waights, J. Y. Brown, S. C. Vatsavayai, M. C. Hirst, and K. P.S.J. Murphy
Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of huntington's disease
Hum. Mol. Genet., October 1, 2006; 15(19): 2856 - 2868.
[Abstract] [Full Text] [PDF]
V. M. Andre, C. Cepeda, A. Venegas, Y. Gomez, and M. S. Levine
Altered Cortical Glutamate Receptor Function in the R6/2 Model of Huntington's Disease
J Neurophysiol, April 1, 2006; 95(4): 2108 - 2119.
[Abstract] [Full Text] [PDF]
M. A. Ariano, C. Cepeda, C. R. Calvert, J. Flores-Hernandez, E. Hernandez-Echeagaray, G. J. Klapstein, S. H. Chandler, N. Aronin, M. DiFiglia, and M. S. Levine
Striatal Potassium Channel Dysfunction in Huntington's Disease Transgenic Mice
J Neurophysiol, May 1, 2005; 93(5): 2565 - 2574.
[Abstract] [Full Text] [PDF]
N. K. Mazarakis, A. Cybulska-Klosowicz, H. Grote, T. Pang, A. Van Dellen, M. Kossut, C. Blakemore, and A. J. Hannan
Deficits in Experience-Dependent Cortical Plasticity and Sensory-Discrimination Learning in Presymptomatic Huntington's Disease Mice
J. Neurosci., March 23, 2005; 25(12): 3059 - 3066.
[Abstract] [Full Text] [PDF]
G. J. Klapstein and M. S. Levine
Age-Dependent Biphasic Changes in Ischemic Sensitivity in the Striatum of Huntington's Disease R6/2 Transgenic Mice
J Neurophysiol, February 1, 2005; 93(2): 758 - 765.
[Abstract] [Full Text] [PDF]
A. Petersen, J. Gil, M. L.C. Maat-Schieman, M. Bjorkqvist, H. Tanila, I. M. Araujo, R. Smith, N. Popovic, N. Wierup, P. Norlen, et al.
Orexin loss in Huntington's disease
Hum. Mol. Genet., January 1, 2005; 14(1): 39 - 47.
[Abstract] [Full Text] [PDF]
E. Bracci, D. Centonze, G. Bernardi, and P. Calabresi
Engagement of Rat Striatal Neurons by Cortical Epileptiform Activity Investigated With Paired Recordings
J Neurophysiol, November 1, 2004; 92(5): 2725 - 2737.
[Abstract] [Full Text] [PDF]
L. Li, T. H. Murphy, M. R. Hayden, and L. A. Raymond
Enhanced Striatal NR2B-Containing N-Methyl-D-Aspartate Receptor-Mediated Synaptic Currents in a Mouse Model of Huntington Disease
J Neurophysiol, November 1, 2004; 92(5): 2738 - 2746.
[Abstract] [Full Text] [PDF]
H. Li, T. Wyman, Z.-X. Yu, S.-H. Li, and X.-J. Li
Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release
Hum. Mol. Genet., August 15, 2003; 12(16): 2021 - 2030.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|